Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer

NCT06451211 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Stomach Neoplasms
Gastric Cancer
Linitis Plastica of Stomach

Interventions

DRUG: Tislelizumab
DRUG: Oxaliplatin
DRUG: S-1
DRUG: Capecitabine

Sponsor

Sun Yat-sen University